Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection.


Journal

Journal of internal medicine
ISSN: 1365-2796
Titre abrégé: J Intern Med
Pays: England
ID NLM: 8904841

Informations de publication

Date de publication:
02 2023
Historique:
pubmed: 9 12 2022
medline: 5 1 2023
entrez: 8 12 2022
Statut: ppublish

Résumé

The occurrence and healthcare use trajectory of post COVID-19 condition (PCC) is poorly understood. Our aim was to investigate these aspects in SARS-CoV-2-positive individuals with and without a PCC diagnosis. We conducted a population-based cohort study of adults in Stockholm, Sweden, with a verified infection from 1 March 2020 to 31 July 2021, stratified by the severity of the acute infection. The outcome was a PCC diagnosis registered any time 90-360 days after a positive test. We performed Cox regression models to assess baseline characteristics associated with the PCC diagnosis. Individuals diagnosed with PCC were then propensity-score matched to individuals without a diagnosis to assess healthcare use beyond the acute infection. Among 204,805 SARS-CoV-2-positive individuals, the proportion receiving a PCC diagnosis was 1% among individuals not hospitalized for their COVID-19 infection, 6% among hospitalized, and 32% among intensive care unit (ICU)-treated individuals. The most common new-onset symptom diagnosis codes among individuals with a PCC diagnosis were fatigue (29%) among nonhospitalized and dyspnea among both hospitalized (25%) and ICU-treated (41%) individuals. Female sex was associated with a PCC diagnosis among nonhospitalized and hospitalized individuals, with interactions between age and sex. Previous mental health disorders and asthma were associated with a PCC diagnosis among nonhospitalized and hospitalized individuals. Among individuals with a PCC diagnosis, the monthly proportion with outpatient care was substantially elevated up to 1 year after acute infection compared to before, with substantial proportions of this care attributed to PCC-related care. The differential association of age, sex, comorbidities, and healthcare use with the severity of the acute infection indicates different trajectories and phenotypes of PCC, with incomplete resolution 1 year after infection.

Sections du résumé

BACKGROUND
The occurrence and healthcare use trajectory of post COVID-19 condition (PCC) is poorly understood. Our aim was to investigate these aspects in SARS-CoV-2-positive individuals with and without a PCC diagnosis.
METHODS
We conducted a population-based cohort study of adults in Stockholm, Sweden, with a verified infection from 1 March 2020 to 31 July 2021, stratified by the severity of the acute infection. The outcome was a PCC diagnosis registered any time 90-360 days after a positive test. We performed Cox regression models to assess baseline characteristics associated with the PCC diagnosis. Individuals diagnosed with PCC were then propensity-score matched to individuals without a diagnosis to assess healthcare use beyond the acute infection.
RESULTS
Among 204,805 SARS-CoV-2-positive individuals, the proportion receiving a PCC diagnosis was 1% among individuals not hospitalized for their COVID-19 infection, 6% among hospitalized, and 32% among intensive care unit (ICU)-treated individuals. The most common new-onset symptom diagnosis codes among individuals with a PCC diagnosis were fatigue (29%) among nonhospitalized and dyspnea among both hospitalized (25%) and ICU-treated (41%) individuals. Female sex was associated with a PCC diagnosis among nonhospitalized and hospitalized individuals, with interactions between age and sex. Previous mental health disorders and asthma were associated with a PCC diagnosis among nonhospitalized and hospitalized individuals. Among individuals with a PCC diagnosis, the monthly proportion with outpatient care was substantially elevated up to 1 year after acute infection compared to before, with substantial proportions of this care attributed to PCC-related care.
CONCLUSION
The differential association of age, sex, comorbidities, and healthcare use with the severity of the acute infection indicates different trajectories and phenotypes of PCC, with incomplete resolution 1 year after infection.

Identifiants

pubmed: 36478477
doi: 10.1111/joim.13584
pmc: PMC9877994
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

246-258

Informations de copyright

© 2022 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.

Références

Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
BMC Med. 2021 Sep 27;19(1):249
pubmed: 34565368
JAMA. 2022 Feb 08;327(6):559-565
pubmed: 35072716
J Intern Med. 2023 Feb;293(2):246-258
pubmed: 36478477
Crit Care Med. 2018 Sep;46(9):1393-1401
pubmed: 29787415
Lancet Infect Dis. 2022 Apr;22(4):e102-e107
pubmed: 34951953
Euro Surveill. 2006;11(5):103-7
pubmed: 16757847
Lancet Respir Med. 2022 Aug;10(8):761-775
pubmed: 35472304
BMJ Glob Health. 2021 Sep;6(9):
pubmed: 34580069
Lancet Reg Health Eur. 2021 Dec;11:100242
pubmed: 34746909
BMC Public Health. 2013 Jul 18;13:670
pubmed: 23866784
J Intern Med. 2022 Jul;292(1):168-171
pubmed: 35253283
EBioMedicine. 2021 Dec;74:103722
pubmed: 34839263
BMJ. 2021 Jul 26;374:n1648
pubmed: 34312178
Lancet Reg Health Eur. 2021 Sep;8:100186
pubmed: 34386785
Nat Commun. 2020 Oct 9;11(1):5097
pubmed: 33037218
BMJ. 2022 Jan 17;376:e066809
pubmed: 35039315
Nat Commun. 2021 Nov 12;12(1):6571
pubmed: 34772922
Br J Anaesth. 2021 Jun;126(6):e217-e219
pubmed: 33812669
Nat Commun. 2022 Apr 12;13(1):1957
pubmed: 35413949
Lancet Infect Dis. 2021 Oct;21(10):1373-1382
pubmed: 33984263
PLoS Med. 2021 Sep 28;18(9):e1003773
pubmed: 34582441
Eur Heart J. 2022 Mar 14;43(11):1157-1172
pubmed: 35176758
Annu Rev Public Health. 2018 Apr 1;39:453-469
pubmed: 29328877
Crit Care. 2021 Feb 25;25(1):86
pubmed: 33632273
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
Fam Pract. 2013 Oct;30(5):506-13
pubmed: 23825186
Lancet Public Health. 2022 May;7(5):e406-e416
pubmed: 35298894
BMJ. 2021 Dec 29;375:e065834
pubmed: 34965929
Nat Commun. 2022 Apr 5;13(1):1812
pubmed: 35383197

Auteurs

Pontus Hedberg (P)

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Fredrik Granath (F)

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Judith Bruchfeld (J)

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Johan Askling (J)

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Rheumatology, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden.

Daniel Sjöholm (D)

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Michael Fored (M)

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Anna Färnert (A)

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Pontus Naucler (P)

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH